Performance and Advantages
Excellent Performance
The unique, closed-system, 64-well Test Cards of the VITEK 2
system can greatly expand the parameters of your analyses. Each
Test Card is light and compact, thus reducing the weight and volume
of your deliveries, storage and contaminated waste disposal.
Biology: Excellent Performance for Clinical Relevance
Microbiological Identification (ID) focused on:
- Frequency of isolation
- Pathogenicity
- Clinical importance regarding antimicrobic therapy
Antimicrobic Susceptibility Testing (AST) aimed at:
- High-Quality MIC
- Extended MIC ranges that provide data on emerging and low-level
antimicrobic resistances
Advanced EXPERT System (AES)
- ID & MIC results are combined and analyzed by the Advanced
EXPERT System for a new generation of AST performance:
Comprehensive
Antimicrobic
Resistance
Detection
Workflow: Improves Processes with Security & Productivity
Simple, standardized Test Card preparation gives high productivity
with streamlined workflow: Electronic information link provides
full process traceability
- Flexibility allows adaptation to the organization of each
laboratory
- Automation achieves full process control
- Flexible software with intuitive interface allows multiple
users
Therapy: Fast Information on High-Efficacy, Low-Cost Therapy
- Provide rapid results
- Increase clinical utility
- Microbiology service participates in - and adds value to -
the outcome process
- Method is reliable
- Provide chain of assurance in the testing process
- Performance proven by published studies
- Provide relevant results
- Reports provide the highest level of assurance for the therapy
decision process
Economics: Laboratory Investment Leading to Hospital Savings
Laboratory cost benefits include:
- Productivity savings
- Operating costs savings
Rapid reports influence:
- Therapy adjustment savings
- Therapeutic failure costs
- Microbial resistance costs
Outcome: Rapid Information for Efficiency and Cost Containment
Excellent performance and rapid on-line information flow influences:
- Improved patient outcomes
- Early detection of nosocomial infections
- Detection of emerging resistances
- MIC-based epidemiology
Return to VITEK 2
|